Effect of Bosentan on Endothelial Function in Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to investigate if oral treatment with bosentan improves
endothelium-dependent vasodilatation in patients with type 2 diabetes and microangiopathy.
Phase:
Phase 2
Details
Lead Sponsor:
Karolinska Institutet
Collaborators:
Actelion Swedish Heart Lung Foundation The Swedish Research Council